A healthcare policy change passed in France is likely to see the country quickly targeted by medicinal cannabis companies with…
Over the years, the Australian cannabis market has consistently posted revenue growth and is expected to be valued at $1.1…
After witnessing a cash burn of $368k in the previous quarter, Cannabis-based pharmaceutical company Althea Group (ASX: AGH) has entered…
Once again, medical cannabis producer Vitura Health (ASX: VIT) has become the only ASX-listed company operating in the medicinal cannabis…
Australia has made a groundbreaking decision by becoming the first country to legalise the clinical prescribing of MDMA (ecstasy) and…
The medicinal cannabis industry in Australia has been rapidly gaining momentum, reaching an estimated value of approximately $245 million in…